Adam Scott Levy Receives Stock Award at Mineralys Therapeutics Inc (MLYS) — SEC Form 4, Feb 15, 2024
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Adam Scott Levy CIK 0001693134 |
CFO
|
Adam Scott Levy at Mineralys Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$5,709,439
More from this insider at Mineralys Therapeutics Inc
| 2026-02-20 | Award | — | View |
| 2026-01-13 | Sell | -$345,723 | View |
| 2025-11-13 | Sell | -$5,363,716 | View |
| 2025-10-15 | Sell | -$451,984 | View |
| 2025-07-31 | Sell | -$1,077,476 | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $14.25 | 2024-02-13 | A - Award/Grant | 200,000 A | $0.00 | 2034-02-13 | 200,000 Common Stock | Direct |
Footnotes (1)
- F1
- The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter. Show more
Related filings at Mineralys Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
225
institutional managers reporting a position
Largest by reported value
- Catalys Pacific, Llc $213M
- Ra Capital Management, L.P. $208M
- Black Rock, Inc. $159M
5%+ Holders · 13D/G
5 filers
-
Fmr Llc 5.1%
-
Catalys Pacific Fund, LP 10.1%
-
Black Rock, Inc. 5.2%
Other insiders at Mineralys Therapeutics Inc
-
Jon Congleton -$1.91M
-
Brian Taylor Slingsby -$3.01M
-
Eric Warren -$209K
GET /v1/forms/4/0001628280-24-005065
API docs
View Original SEC Filing